Company Details
Scribe Therapeutics
Overview
Biotech company developing advanced CRISPR-based therapeutics.
Total Raised
$145 M
Rounds
3
Links
Verticals
Biotechnology
Life Science
Therapeutics
Investment History
Grant
Jun 2026
$25M
Series B
Mar 2021
$100M
Series A
Oct 2020
$20M